In Situ Self‐Aggregation of Spirulina Skeleton Fibers Enhances the Efficacy of Anti‐Tumor Thermal Immunotherapy
Source abstract
Abstract
Abstract The lack of broad‐spectrum tumor antigens, limited immunogenicity of antigens, and immunosuppressive microenvironment in tumors have impeded the development of cancer vaccines. To address this issue, a vaccine platform is developed based on Spirulina skeleton fibers loaded with gold (Au) nanoparticles (Au@E‐SP). Upon subcutaneous administration, Au@E‐SP self‐aggregates in situ and forms a 3D vaccine scaffold owing to its elongated and helical architecture. Through the aggregation of Au@E‐SP, Au nanoparticles are concentrated, which significantly enhances the local photothermal effect and releases more tumor‐associated antigens. In addition, the retained E‐SP serves as a natural immune adjuvant that sustainably reverses the immunosuppressive microenvironment in vivo. Combining these advantages, the vaccines induce a potent anti‐tumor immune response, effectively inhibiting tumor recurrence and metastasis. This strategy utilizes microalgae as a self‐adjuvant vaccine, providing a promising avenue for further research in tumor immunotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry Wuhan University Wuhan 430072 P. R. China
Funding
National Natural Science Foundation of China
References (60)
Show source-provided references
1. 10.1016/j.cell.2017.01.01710.1016/j.cell.2017.01.017 ↗
2. 10.1038/s41392-022-01136-210.1038/s41392-022-01136-2 ↗
3. 10.3390/ijms2101017010.3390/ijms21010170 ↗
4. 10.1038/s41571-021-00473-510.1038/s41571-021-00473-5 ↗
5. 10.1126/science.aar406010.1126/science.aar4060 ↗
6. 10.1038/nrc393010.1038/nrc3930 ↗
7. 10.1038/s41563-018-0091-810.1038/s41563-018-0091-8 ↗
8. 10.1038/nri286810.1038/nri2868 ↗
9. 10.1038/s41568-021-00346-010.1038/s41568-021-00346-0 ↗
10. 10.1016/j.immuni.2010.10.00210.1016/j.immuni.2010.10.002 ↗
11. 10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.0.CO;2-H10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.0.CO;2-H ↗
12. 10.1158/1078-0432.CCR-10-312610.1158/1078-0432.CCR-10-3126 ↗
13. 10.1517/14728214.13.2.29510.1517/14728214.13.2.295 ↗
14. 10.1038/s41568-021-00397-310.1038/s41568-021-00397-3 ↗
15. 10.1038/s41591-021-01233-910.1038/s41591-021-01233-9 ↗
16. 10.1038/s41571-020-00460-210.1038/s41571-020-00460-2 ↗
17. 10.1038/s41467-022-33831-710.1038/s41467-022-33831-7 ↗
18. 10.1016/j.ccell.2022.10.01310.1016/j.ccell.2022.10.013 ↗
19. 10.1038/nrc.2016.1610.1038/nrc.2016.16 ↗
20. 10.1038/s41467-022-32645-x10.1038/s41467-022-32645-x ↗
21. 10.1038/s41565-022-01125-010.1038/s41565-022-01125-0 ↗
22. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
23. 10.1002/adma.20190262610.1002/adma.201902626 ↗
24. 10.1002/adma.20221045210.1002/adma.202210452 ↗
25. Habib A. · Iran. J. Immunol. · 2023 · 20 · 1
26. 10.1080/21691401.2018.151394110.1080/21691401.2018.1513941 ↗
27. 10.1360/972012-72010.1360/972012-720 ↗
28. 10.1038/nbt.307110.1038/nbt.3071 ↗
29. 10.1021/acsnano.3c0237310.1021/acsnano.3c02373 ↗
30. 10.1038/s41467-021-27750-210.1038/s41467-021-27750-2 ↗
31. 10.1126/science.aar691810.1126/science.aar6918 ↗
32. 10.1038/s41578-021-00399-510.1038/s41578-021-00399-5 ↗
33. 10.1016/S0264-410X(00)00354-610.1016/S0264-410X(00)00354-6 ↗
34. 10.1016/j.biomaterials.2021.12129710.1016/j.biomaterials.2021.121297 ↗
35. 10.1002/adma.20210925410.1002/adma.202109254 ↗
36. 10.1002/VIW.2020018910.1002/VIW.20200189 ↗
37. 10.1038/s41587-022-01249-710.1038/s41587-022-01249-7 ↗
38. 10.1002/adtp.20200010710.1002/adtp.202000107 ↗
39. 10.1021/acsami.8b1558610.1021/acsami.8b15586 ↗
40. 10.1038/s41467-022-28744-410.1038/s41467-022-28744-4 ↗
41. 10.1126/sciadv.abi926510.1126/sciadv.abi9265 ↗
42. 10.1016/j.algal.2018.07.01310.1016/j.algal.2018.07.013 ↗
43. Ali S. K. · Int. J. Pharm. Pharm. Sci. · 2012 · 4 · 9
44. 10.21037/tcr.2019.06.1310.21037/tcr.2019.06.13 ↗
45. 10.1016/S1567-5769(01)00166-710.1016/S1567-5769(01)00166-7 ↗
46. 10.1586/erv.12.3810.1586/erv.12.38 ↗
47. 10.1128/CVI.00036-1010.1128/CVI.00036-10 ↗
48. 10.1016/j.biomaterials.2021.12072410.1016/j.biomaterials.2021.120724 ↗
49. 10.1038/s41571-022-00717-y10.1038/s41571-022-00717-y ↗
50. 10.1126/sciadv.abo528510.1126/sciadv.abo5285 ↗
51. 10.1038/s41551-023-01014-410.1038/s41551-023-01014-4 ↗
52. 10.2147/IJN.S23378910.2147/IJN.S233789 ↗
53. 10.1021/acs.chemrev.2c0091410.1021/acs.chemrev.2c00914 ↗
54. 10.1038/s41579-023-00862-w10.1038/s41579-023-00862-w ↗
55. 10.3109/1743539090347146310.3109/17435390903471463 ↗
56. 10.1016/j.ccell.2023.01.00910.1016/j.ccell.2023.01.009 ↗
57. 10.1007/BF0039566410.1007/BF00395664 ↗
58. 10.1016/j.semcdb.2009.06.00210.1016/j.semcdb.2009.06.002 ↗
59. 10.1016/j.yexmp.2006.06.00710.1016/j.yexmp.2006.06.007 ↗
60. 10.1007/s10856-017-5949-910.1007/s10856-017-5949-9 ↗